These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 5137252

  • 1. [Hair changes in immunosuppressive therapy].
    Kostanecki W, Mazurkiewicz W, Górkiewicz A, Zborzil J.
    Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of chronic diseases of connective tissue by cytostatic drugs].
    Deicher H, Fricke R, Kruli P.
    Rev Clin Esp; 1970 Mar; 116(6):539-48. PubMed ID: 4996836
    [No Abstract] [Full Text] [Related]

  • 3. [So-called immunosuppressive cytotoxic medication in acute disseminated lupus erythematosus and scleroderma].
    Thivolet J, Perrot H.
    Bull Soc Fr Dermatol Syphiligr; 1970 Mar; 77(3):412-4. PubMed ID: 5510738
    [No Abstract] [Full Text] [Related]

  • 4. [Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
    Schuppli R.
    Minerva Med; 1970 Jul 11; 61(55):3070-3. PubMed ID: 5427679
    [No Abstract] [Full Text] [Related]

  • 5. [Positive and negative effects of cytostatic therapy in rheumatic patients].
    Krampac I.
    Reumatizam; 1970 Jul 11; 17(2):51-4. PubMed ID: 5311483
    [No Abstract] [Full Text] [Related]

  • 6. [Immunologic tissue damage and immunosuppression].
    Holm O.
    Lakartidningen; 1976 Apr 21; 73(17):1624-8. PubMed ID: 1083468
    [No Abstract] [Full Text] [Related]

  • 7. [Infections and lymphoma during prolonged immunosuppression in vascular diseases].
    Guillevin L.
    Rev Med Interne; 2005 Oct 21; 26 Spec No 1():35-8. PubMed ID: 16475263
    [No Abstract] [Full Text] [Related]

  • 8. [Infections and immunosuppressive agents in rheumatology].
    Kahn MF, Vitale C, Grimaldi A.
    Sem Hop; 2005 Oct 21; 52(22-23):1374-6. PubMed ID: 183273
    [Abstract] [Full Text] [Related]

  • 9. [Side-effects of cytostatic and immunosuppressive therapy].
    Hartwich G.
    Fortschr Med; 1973 Mar 22; 91(9):357-62. PubMed ID: 4633019
    [No Abstract] [Full Text] [Related]

  • 10. [Hepatotoxicity of antimitotic treatments. Effect of hepatic tests].
    Robert J, Barbier P, Manaster J, Jacobs E.
    Rev Int Hepatol; 1968 Mar 22; 18(3):427-44. PubMed ID: 5685733
    [No Abstract] [Full Text] [Related]

  • 11. [Immunosuppressive agents in dermatology].
    Schuppli R.
    Dtsch Med Wochenschr; 1970 Dec 18; 95(51):2576-7. PubMed ID: 5513651
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive treatment of collagen diseases].
    Cruchaud A.
    Ther Umsch; 1969 Dec 18; 26(12):697-702. PubMed ID: 5386688
    [No Abstract] [Full Text] [Related]

  • 13. Use of anticancer drugs during pregnancy.
    Stutzman L, Sokal JE.
    Clin Obstet Gynecol; 1968 Jun 18; 11(2):416-27. PubMed ID: 4879373
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of chronic connective tissue diseases with cytostatics].
    Deicher H, Fricke R, Krull P.
    Minerva Med; 1970 Jul 11; 61(55):3040-53. PubMed ID: 4987808
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppressive and cytotoxic drugs in dermatology.
    Dantzig PI.
    Arch Dermatol; 1974 Sep 11; 110(3):393-406. PubMed ID: 4141602
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical picture of rheumatologic diseases. Current status of cytostatic therapy].
    Chlud K.
    Verh Dtsch Ges Rheumatol; 1974 Sep 11; 3(0):257-60. PubMed ID: 4839653
    [No Abstract] [Full Text] [Related]

  • 17. [Medicamental immunosuppression in dermatology (author's transl)].
    Goerz G, Merk H.
    Z Hautkr; 1981 Aug 01; 56(15):975-90. PubMed ID: 7269720
    [Abstract] [Full Text] [Related]

  • 18. [Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
    Schulze P.
    Z Arztl Fortbild (Jena); 1977 Jun 15; 71(12):562-4. PubMed ID: 20701
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppressive and cytotoxic drugs: uses in the dermatologic patient.
    Callen JP.
    Adv Dermatol; 1990 Jun 15; 5():3-19; discussion 20. PubMed ID: 2204377
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA, McCune WJ.
    Rheum Dis Clin North Am; 1994 Feb 15; 20(1):265-99. PubMed ID: 8153402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.